Roche (RHHBY) reported that its fiscal 2024 IFRS net income decreased by 19%, or 26% in Swiss francs, to 9.2 billion francs, mainly ...
Effective February 10, 2025, Mamilli will assume global responsibility for the Informatics function for the Roche Group.
EARNINGS FORECAST: Roche's core earnings per share are expected to come in at 18.59 francs, according to the Visible Alpha consensus. For 2023, the company reported core EPS of 18.57 francs. As of ...
Mumbai: Roche Pharma India has announced the appointment of Rajwinder (Rajji) Mehdwan as country General Manager, effective 1 ...
Roche’s freshly approved PI3K inhibitor Itovebi can help extend the lives of certain patients with breast cancer when used in ...
Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics.Excluding COVID-19, Group sales increased by 9%.
To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Roche has a big problem. With competition threatening some of its older and most lucrative biologic drugs, ...
Roche has obtained U.S. government green lights allowing its point-of-care testing system to be used to screen for multiple ...